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atrioventricular canal defects
Muralidhar Padala, BS,a Nikolay V. Vasilyev, MD,b James W. Owen, Jr, BS,a Jorge H. Jimenez, PhD,a Lakshmi P. Dasi, PhD,a
Pedro J. del Nido, MD,b and Ajit P. Yoganathan, PhDa
Objective: Reoperation rates to correct left atrioventricular valve regurgitation after primary repair of atrioven-
tricular canal defects remain relatively high. The causes of valvular regurgitation are likely multifactorial, and
simple cleft closure is often insufficient to prevent recurrence.
Methods: To elucidate the mechanisms leading to regurgitation, we conducted hemodynamic studies using
isolated native mitral valves. Anatomy of these valves was altered to mimic atrioventricular canal type valves
and studied under pediatric hemodynamic conditions. The impact of subvalvular geometry, cleft closure, annular
dilatation, and annular undersizing on regurgitation were investigated.
Results: Papillary muscle position did not have a significant effect on regurgitation. Cleft closure had a significant
impact on valvular competence, with reduction in regurgitation volume with increased cleft closure. Regurgita-
tion volume decreased from 12.5 2.4 mL/beat for an open cleft to 4.9  1.9 mL/beat for a partially closed cleft
and to 1.4  1.6 mL/beat when the cleft was completely closed. Annular dilatation had a significant impact on
regurgitation even after cleft closure. A 40% increase in annular size increased regurgitation by 59% for a par-
tially closed cleft and by 84% for a fully closed cleft. Reducing the annular size by 20% from the physiologic
level decreased the regurgitation volume by 12% for a fully open cleft and by 58% for the partially closed cleft
case.
Conclusions: Annular dilatation after primary repair has a potentially significant role in the recurrence of atrio-
ventricular valve regurgitation. Reducing the annular size and restricting dilatation as an adjunct to cleft closure is
a promising surgical approach in such valve anatomies.In the current era of surgical repair for congenital atrioventric-
ular canal (AVC) defects, the measure of operative success
has shifted from early mortality to freedom from reoperation
to correct residual lesions. In these patients, repair of the sep-
tal defects has been highly successful, but progressive postre-
pair regurgitation across the left atrioventricular (LAV) valve
still remains a challenging problem. More than 15% of the
patients surviving AVC repairs have hemodynamically sig-
nificant regurgitation, the causes of which are unknown.1-4
Poor understanding of the underlying mechanisms causing
postrepair LAV valve regurgitation has impeded progress
toward optimizing valve repair in these patients.5
Unlike repair for other valve lesions, surgical guidelines
for LAV valve reconstruction in AVC defects are unclear,
resulting in evolution of a variety of unsuccessful repair pro-
cedures that often result in valve replacement.2,6,7 Long-
term follow-up studies on these patients are scarce, so that
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stand the failure mechanisms. Key surgical questions such
as the optimal length of cleft closure,8,9 impact of abnormal
ventricular geometry,8,10,11 and growth of valvular struc-
tures after the repair remain unanswered.With the increasing
number of AVC repairs performed every year, there is an im-
mediate need to optimize valve repair in these patients by
understanding the LAV valve hemodynamics under con-
trolled conditions. Large animal models are ideal for such
studies, but creating congenital anatomies in animals is yet
to be accomplished. In this study, we present a novel in vitro
method using porcine mitral valves to investigate the role of
preoperative valve geometry, surgical procedure, and post-
operative geometry on hemodynamics of the LAV valve.
In particular, we investigate the impact of cleft closure, ven-
tricular geometry, postoperative annular dilatation, and
annular undersizing on valvular regurgitation.
METHOD
Valve Preparation
Eight mitral valves (24-mm size) were extracted from fresh porcine
hearts (female pigs aged 4–6 months, weighing 100–120 kg) obtained
from the local abattoir. The geometry of these native valves was altered
to mimic the anatomy and function of the pathologic LAV valve in AVC
defects, as shown in Figure 1. The P2 segment of the posterior leaflet was
resected and the free edges were approximated with 4-0 Prolene polypropyl-
ene sutures (Ethicon, Inc, Somerville, NJ) (Figure 1, A–D), mimicking the
smaller triangular posterior leaflet in AVC-like valves8,10 shown in Figure 1,
E. The valve was then sutured onto a semi-oval annulus, with the curved
portion of the semi-oval forming the posterior annulus and the straightardiovascular Surgery c Volume 136, Number 5 1243




AVC ¼ atrioventricular canal
EOA ¼ effective orifice area
LAV ¼ left atrioventricular
PM ¼ papillary muscle
part of the semi-oval forming the anterior annulus (Figure 1). The papillary
muscles (PMs) were wrapped in Dacron fabric and mounted on an adjust-
able geared fixture that allowed PM displacement in the apical, posterior,
and lateral directions.12 The valves were then mounted into the in vitro
experimental setup.
In Vitro Experimental Setup
The in vitro experimental setup used in this study is widely established
and has been used in various studies on ischemic and degenerative mitral
valve repairs.12-14 In brief, the left heart simulator (Figure 2, A) is a com-
puter-controlled, pressure-driven, compressible bladder system that can
simulate various pulsatile hemodynamic conditions of the left heart. It has
a semi-oval silicone mitral annulus, whose size can be adjusted to desired
levels (18–48 mm valve sizes) using a drawstring mechanism. This mech-
anism allows for segmental annular reduction and dilatation of the posterior
annulus, keeping the anterior annulus at a constant length. The PMs are
mounted onto an adjustable fixture that allows spatial displacement in the
apical–basal, posterior–anterior, and lateral dimensions. Saline solution,
0.9% vol/vol, as the working media and the chamber pressure and flow
curves are monitored and recorded in real time with a differential pressure
transducer (DP9-40; Validyne Engineering, Northridge, Calif), an electro-
magnetic flow probe (600 Series; Braemar Inc, St Paul, Minn), and a data
acquisition system (DAQCARD 1200; National Instruments, Austin, Tex).
Experimental Protocol
All 8 valves were studied under the following experimental conditions:
Baseline (control) conditions. Before the valve geometry was al-
tered to an AVC-like valve, all the valves were studied under pediatric he-
modynamic conditions: 120 beats/min heart rate, 85 mm Hg peak left
ventricular pressure, and an average cardiac output of 2.5 L/min. Annular
size was maintained at the normal valve size (measured before valve extrac-
tion from the heart) with the PMs in their normal positions. The normal po-
sition of the PMswas determined such that the commissural chordae were in
a single plane and the tips of the PMs were in the plane passing through the
leaflet coaptation.
Disease conditions. The native valve geometry was then altered to
mimic the AVC-like valve (Figure 1), and the experiments were repeated
under the same pediatric hemodynamic conditions. First, the effect of abnor-
mal ventricular geometry was studied with the PMs in their normal position
(baseline) and by displacing them by 10 mm in the posterior and lateral di-
rections (Figure 1, F), mimicking a scooped ventricular geometry found in
these patients. After this step, a wedge-shaped anterior leaflet cleft was cre-
ated by removing a triangular section of the anterior leaflet skirt from the
free edge to the mitral annulus, as illustrated in Figure 1, F. The oblique
PM position was maintained hereafter.
Repair and postrepair conditions
Cleft closure. The valve was repaired by closing the cleft to four levels:
fully open cleft, one-third closed cleft, two-thirds closed cleft, and fully
closed cleft, as shown in Figure 2, B. The total cleft length was measured
in each valve and divided into three equal parts to determine the above cleft
closure levels. Then, 4-0 Prolene polypropylene sutures were used to close
the cleft in an interrupted knot fashion, and the valves were studied under
pediatric hemodynamic conditions as previously used.1244 The Journal of Thoracic and Cardiovascular SuAnnular dilatation. The impact of annular dilatation after cleft closure
was studied by dilating the annulus to 20% and 40% of its normal area. In
all the valves, the annular area was 4.0 cm2 initially and was increased to 4.8
cm2 to mimic 20% dilatation and to 5.6 cm2 for the 40% dilated size. These
two levels of dilatation represent the mitral annular growth from infancy to 5
years of age, assuming the repair was conducted during infancy.15 The
effect of annular dilatation was studied on the four cleft closure lengths.
Annular undersizing. The efficacy of annular undersizing as an ad-
junct procedure was investigated by undersizing the annulus from its normal
size of 4.0 cm2 to 3.2 cm2, simulating 20% undersizing, and to 2.4 cm2, sim-
ulating 40% undersizing. The effect of undersizing was studied on the four
cleft closure lengths.
Data Acquisition and Measured End Points
For all the experimental conditions, the transmitral and left ventricular
pressures and the transmitral flow rate were recorded and the following
end points were calculated:
Regurgitation volume. The transmitral flow curve was averaged
over 15 cardiac cycles and the negative part of the flow curve was integrated
to obtain the regurgitation volume per beat.
Effective orifice area (EOA). To assess valve stenosis, we calcu-
lated the diastolic EOA for each valve under all experimental conditions us-
ing the modified Gorlin equation: EOA¼Qrms / (51.6[ODPmean]) expressed
in square centimeters, where Qrms (diastolic root mean square flow rate) and
DPmean (mean diastolic transmitral pressure gradient) is used from averaged
transmitral pressure and flow data.
Echocardiographic study. Three-dimensional echocardiographic
measurements were obtained with an X7-2 pediatric 3-dimensional matrix
array probe (iE33 System; Philips Medical Systems, Andover, Mass) at
3.75 MHz, at the highest possible frame rate at a sampling depth of 12
cm. Two-dimensional echoes along the apical long-axis view cutting across
both the leaflets anteroposteriorly at the midpoint of the major axis of the
annulus were also obtained. Echocardiographic and color doppler images
were obtained to assess the forward flow and the leakage flow through
the cleft and the coaptation regions.
Statistical Analysis
All the data are reported as mean  1 standard deviation. The data were
tested for normality by an Anderson–Darling test (MINITAB 15). Different
experimental groups were compared by paired t tests.
RESULTS
Effect of Smaller Posterior Leaflet and Oblique PM
Position
The smaller posterior leaflet by itself without the cleft did
not affect valve function, with statistically insignificant
changes (P ¼ .12) between the normal (0 mL/beat) and
AVC-like valves (0.2  0.1 mL/beat). Oblique displacement
of the PMs did not disturb valve function, with the regurgita-
tion volumes of 0 mL/beat (normal PM position) versus 0.7
 0.3 mL/beat (oblique) at normal annular size. Similarly, at
a 40% dilated annular size, the regurgitation volume was 9.5
 2.3 (normal) versus 9.3 2.5 mL/beat (oblique) (P¼ .77).
Length of Cleft Closure
Figure 3 illustrates the comparison between regurgitation
volumes for the four cleft closure levels with a normal size
annulus. With the cleft fully open, a regurgitation volume
of 12.56 2.4mL/beat was obtained. One-third cleft closurergery c November 2008
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C
H
DFIGURE 1. Sequential steps to alter the native mitral valve geometry to mimic the left atrioventricular valve in the canal defects. The dotted circles indicate
the position of the papillary muscles. A, Native mitral valve. B, Resection of the P2 segment of the posterior leaflet. C, Plication of the annulus. D, The free
ends of the resected section are sutured together, forming a smaller posterior leaflet. E, Posterior lateral displacement of the papillary muscles. F, The anterior
leaflet skirt is sectioned to mimic the cleft. The images on the right (G and H) compare the valve structure with cleft (arrow) obtained from our in vitro setup
under pulsatile hemodynamic conditions with one obtained from a patient, using 3-dimensional echocardiography. SBL, Superior bridging leaflet; IBL,
inferior bridging leaflet; ML, mural/posterior leaflet; LVOT, left ventricular outflow tract.reduced it to 9.96 2.1 mL/beat and was significantly lower
from the fully open cleft (P ¼ .001). A two-thirds cleft clo-
sure resulted in 4.9  1.9 mL/beat (P ¼ .001) and 1.4  1.6
mL/beat (P ¼ .001) for complete cleft closure.
Post-repair Annular Dilatation
Annular dilatation significantly increased the regurgitant
volume irrespective of the length of cleft closure, as shown
in Figure 4, A. For a fully open cleft, the regurgitant volume
increased from 12.2 2.1 mL/beat at normal annulus size to
13.7  1.1 mL/beat for 20% dilatation and 14.7  0.8 mL/
beat for 40% dilatation. When a third of the cleft was closed,
a 20% increase in the annular size increased the regurgitant
volume to 12.1  2.4 mL/beat from 9.9  2.8 mL/beat at
normal size (P ¼ .001) and to 14.0  1.7 mL/beat at 40%
dilatation, which was significantly different from the normal
annulus (P¼ .002) and the 20% dilated annulus (P¼ .007).
For the two-thirds cleft closure, the regurgitant volume
changed from 4.7  3.3 mL/beat at normal annulus size to
8.5  2.5 mL/beat (P ¼ .002) and 11.4  1.8 mL/beat (P
¼ .0001) for 20% and 40% annular dilatation, respectively.The Journal of Thoracic and CaEven when the cleft was fully closed, the regurgitant vol-
umes increased from 1.4  2.8 mL/beat at normal annular
size to 4.5  2.3 mL/beat (P ¼ .0001) for 20% dilatation
and 8.7  1.5 mL/beat (P ¼ .0001) for 40% dilatation.
Effect of Annular Undersizing on Regurgitation
Volume
Figure 4, B, illustrates the effect of undersizing the annu-
lus on the regurgitant volume for the four cleft closure
lengths. For the fully open cleft, regurgitation volume de-
creased from 12.56  2.4 mL/beat to 10.83  1.8 mL/beat
for 20% undersizing and to 9.8  1.9 mL/beat for 40% an-
nular undersizing (P¼ .03). Similarly, for the one-third cleft
closure length, 20% undersizing decreased regurgitant vol-
ume from 9.95 3 mL/beat to 7.78 2 mL/beat (P¼ .007)
and an additional 20% undersizing reduced it to 4.44  1.9
mL/beat (P ¼ .001). For the two-thirds cleft closure length,
the regurgitation volume decreased from 4.73 2.8 mL/beat
at the normal annular size to 2.05  2.1 mL/beat (P ¼ .518)
for 20% undersizing and to 0.7  1.2 mL/beat (P ¼ .533)
for 40% undersizing. The P values are in comparison withrdiovascular Surgery c Volume 136, Number 5 1245
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DFIGURE 2. A, The schematic of the in vitro left heart simulator shows a native porcine mitral valve mounted into the simulator with the various components
of the system labeled. B, The three different lengths of cleft closure that were studied.the regurgitation volume of the valve with a smaller poste-
rior leaflet and obliquely placed PMs, and without an ante-
rior cleft.
Diastolic EOA—Prerepair and Postrepair
Conditions
For all the valves, diastolic EOA was calculated before
and after the repair, and the results are illustrated in Figure 5.
No statistically significant changes were observed between
the preoperative and postoperative groups (P ¼ .734), sug-
gesting absence of valve stenosis even after annular under-
sizing. Small increases in the effective orifice areas were
observed where the cleft was partially open.1246 The Journal of Thoracic and Cardiovascular SuDISCUSSION
Clinical outcomes after correction of AVC defects depend
largely on the surgical procedure and postoperative LAV
valve function. In this study, we demonstrate the benefit of
complete cleft closure on LAV valve competence in an in
vitro AVC-like valve model. These results agree with the
clinical findings fromWetter and associates9 in their compre-
hensive study on 96 patients over a period of 13 years and
confirm the benefits of cleft closure. Despite complete cleft
closure, these patients had progressively increasing LAV
valve regurgitation resulting in high reoperation rates.16-18
A critical component of this study demonstrates the impact
of postoperative annular dilatation on the repair, and theFIGURE 3. A, Regurgitation volumes obtained for open, one-third closed, two-thirds closed, and completely closed cleft lengths. B, Normalized regurgi-
tation volume plotted against the cleft closure length for each valve. Normalized regurgitation volume was obtained by dividing the regurgitation volume for
the one-third, two-thirds, and fully closed conditions with the corresponding open cleft regurgitation volume. The equation clearly shows a negative corre-
lation between the regurgitation volume and the cleft closure length.rgery c November 2008
Padala et al Surgery for Congenital Heart DiseaseFIGURE 4. A, Increase in the systolic regurgitation volume owing to annular dilatation for the three levels of cleft closure. B, Decrease in the systolic
regurgitation volume with 20% and 40% annular undersizing for the three levels of cleft closure.C
H
Dresults suggest that small magnitudes of postoperative annu-
lar dilatation induced in valve incompetence even after cleft
closure, suggesting that isolated cleft closure is insufficient
and the annulus has to be addressed as well.
To overcome the unavailability of large animal models,
we adopted an in vitro method that simulates AVC-like
valve anatomy and function, as shown in Figure 1, G and
H.1 [1]. Although in vitro methodology is limited by its rigid
ventricular chamber, nonphysiologic ventricular shape, lack
of annular dynamics, and absence of chordal attachments
from the ventricular wall, as seen in AVC patients, these lim-
itations do not affect the variables that were investigated in
this study. Additionally, the in vitro approach provides pre-
cise control over the valve geometry and hemodynamic con-
ditions and also provides the ability to study different repair
procedures on the same valve.
Previous clinical studies have reported that the key to
competence of the trifoliate LAV valve is the zone of appo-
sition (cleft) between its bridging leaflets.2,7,9 The findings
from this study confirm these clinical observations and pro-
vide novel insights into the interaction between the degree of
cleft opening and annular size after primary valve repair in
AVC defects. Given the anatomic constraints in leaflet size
FIGURE 5. Comparison of the diastolic effective orifice areas obtained for
the prerepair and postrepair conditions.The Journal of Thoracic and Cand mobility in the AVC defect valves, such an understand-
ing can aid surgical decision-making. The regurgitation
volume measured in this study decreased by 18% for
a one-third cleft closure, by 61% for a two-thirds closed
cleft, and by 90% in the case of a completely closed cleft
in comparison with a fully open cleft. These data suggest
that if a partial cleft closure is intended, at least two thirds
of the cleft should be closed to achieve hemodynamic bene-
fits. Closing the cleft in the vicinity of the annulus leaves
a majority of the cleft open, allowing regurgitation. When
more than two thirds of the cleft is closed, regurgitation is
prevented inasmuch as the small portion of the cleft that is
left open extends into the leaflet coaptation. Often, mild re-
gurgitation persists (Figure 6) through this region because
the edges of the cleft are thin and unstable at high systolic
pressures. Complete closure of the cleft restored excellent
valve competence (91% reduction) with good leaflet mobil-
ity observed on the echo. However, complete closure of the
cleft can potentially cause valvular stenosis in patients with
a parachute valve or closely spaced PMs. Leaving the cleft
partially open, in this group, might aid efficient diastolic
left ventricular filling.
Although cleft closure greatly improves immediate surgi-
cal outcome, postrepair annular dilatation would have a sig-
nificant negative impact on the long-term repair durability.
Our results suggest that annular dilatation causes significant
recurrence of regurgitation notwithstanding cleft closure.
With a 20% increase in annular size, regurgitation volumes
increased up to 45% for a two-thirds cleft closure and by
69% for complete cleft closure. At 40% annular dilatation,
regurgitation increased by 59% for the two-thirds cleft clo-
sure and by 84% for the complete cleft closure. An interest-
ing inference from these results is the higher gradient of
increase in regurgitation resulting from annular dilatation
for a fully closed cleft compared with a partially closed cleft.
We speculate that for a complete cleft closure, chordae in-
serting into the anterior leaflet edges tether on the leaflets,
which could be confounded by annular dilatation causing in-
creased regurgitation confirmed by our color Doppler data in
Figure 6. Normal mitral valve leaflets compensate up toardiovascular Surgery c Volume 136, Number 5 1247
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H
DFIGURE 6. Three-dimensional full volume color Doppler images obtained at peak systolic valve closure. The images in the first row depict the reduction in
the regurgitation volume with increasing cleft closure. The second row illustrates the recurrent regurgitation with dilatation of the annulus in all the cases
of cleft closure. Images in the third row illustrate the efficacy of reducing the annular size in restoring valve coaptation even with a partial cleft closure.
A, Anterior; P, posterior.80% annular dilatation before leaking.14 However, in these
AVC-type valves, the posterior leaflet is nearly half the nor-
mal size, reducing the compensatory mechanisms. This im-
portant valve feature has to be acknowledged during valve
repair. Posterior leaflet augmentation techniques could be
beneficial in this scenario, but they are challenging to per-
form in infants owing to the fragility of leaflet tissue and
the risk of cutting the chordae.
Annular undersizing may be a promising alternative to
patch augmentation in these patients. In our study, we dem-
onstrate that 20% annular undersizing with two-thirds cleft
closure restored good valve competence by reducing the re-
gurgitation by 58% from the normal annular size. A similar
trend was observed with one-third cleft closure as well, but
at 40% undersizing, which might cause valvular stenosis.
Undersizing in these patients could serve three purposes: re-
strict annular dilatation, enhance leaflet coaptation, and re-
store complete valve competence with only a partial cleft
closure. Inasmuch as AVC defects are corrected during in-
fancy, restricting annular dilatation during the initial years
after the repair could prevent late regurgitation. However,
this procedure has to be considered cautiously, and adult1248 The Journal of Thoracic and Cardiovascular Smitral annuloplasty rings should not be used owing to their
rigidity and lack of growth potential, potentially causing ste-
nosis in the long term. Using polydioxanone or absorbable
annuloplasty rings is recommended because they allow
somatic growth of the annulus by gradual degradation with
time.19 This strategy may attenuate early morbidity and
also allow for better long-term valve growth and perfor-
mance. This study also supports the hypothesis that a partial
cleft closure is sufficient when undersizing the annulus. Ac-
knowledging this fact is useful when confronting difficult
anatomies such as in valves with a single PM. Additionally,
the open part of the cleft could provide better leaflet mobil-
ity,10 benefiting diastolic ventricular filling.
Although the in vitro model adopted in this study simu-
lates human AVC-like valve anatomy and function to
a good extent, it has some inherent limitations. In this model,
chordal attachments in the cleft vicinity inserting from the
ventricular septum (Rastelli type A) were not simulated.
These chordal attachments could contribute to some extent
to the postoperative regurgitation. The rigid ventricular
chamber used in this study does not mimic the ventricular
motion, whose effects on the valve functionwere not studied.urgery c November 2008
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H
DIn summary, this study provides novel mechanistic in-
sights into a complex problem of LAV valve repair in
AVC defects. Cleft closure and postoperative annular dilata-
tion have a significant impact on repair outcome. To reduce
reoperation rates and to maintain long-term valve compe-
tence, we demonstrate that cleft closure with annular under-
sizing is proven to be beneficial.
We acknowledge Holifield Farms, Covington, Georgia, for
donating porcine hearts that were used in this study.
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